Mayo Clinic Cardiovascular CME

https://feed.podbean.com/cardiovascularcmemayoclinic/feed.xml

325.9K

Downloads

233

Episodes

The Cardiovascular CME podcast is a new educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.

Episodes

Tuesday May 28, 2024

Lung Transplant

Tuesday May 28, 2024

Lung Transplant

Guest: Philip J. Spencer, M.D.

Hosts: Malcom Bell, M.D.

Lung transplant has evolved over the last 4 decades to be come the only “durable” treatment for end stage lung failure and pulmonary hypertension. Long-term survival remains a challenge however is improving with time while the severity of illness we can treat continues to expand

Topics Discussed:

What patients are we currently treating with lung transplantation and how has this changed over time.
What tools have evolved over the last 10-15 years that have increased our ability to expand lung transplantation to older and more severely ill patients?
What areas do you see as a focus for improvement in the next decade in the field of lung transplantation?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday May 21, 2024

All About Comparison ECGs for 12-Leads and Arrhythmias

Tuesday May 21, 2024

All About Comparison ECGs for 12-Leads and Arrhythmias

Guest: Ken Grauer, M.D.

Host: Anthony H. Kashou, M.D.

In this episode, we explore the importance of clinically correlated ECGs, including the optimal techniques for ECG comparison, the role of clinical history in this process, and the applications of comparison tracings for cardiac arrhythmias.

Topics Discussed

What can we learn from clinically correlated Comparison of ECGs?
What is the optimal technique for comparing one tracing with another

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday May 14, 2024

Advances in Understanding Bicuspid Aortic Valve

Tuesday May 14, 2024

Advances in Understanding Bicuspid Aortic Valve

Guest: Hector I. Michelena, M.D.

Hosts: Patricia A. Pellikka, M.D.

The congenital bicuspid aortic valve (BAV) is the most common congenital heart defect, affecting 1% of the population (2% in men and 0.5% women), with men to women ratio of 2:1 to 3:1, and it is characterized by heterogeneity of phenotypic expression and outcomes.

Topics Discussed:

What is bicuspid aortic valve and why is it important?
What is meant by saying that it is a heterogeneous disease?
What is the natural history of the disease?
What are the differences between BAV AS and TAV AS? What about BAV AR and TAV AR?
Are there sex differences in BAV disease?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday May 07, 2024

ICI Myocarditis

Tuesday May 07, 2024

ICI Myocarditis

Guest: Joerg Herrmann, M.D.

Hosts: Sharonne Hayes, M.D.

At the end of this recording, the listener will have an understanding of the use of immune checkpoint inhibitors (ICIs) and their cardiovascular side effects, which include myocarditis, heart failure, and acute coronary events. Challenges in diagnosis and treatment of these cardiovascular events will be discussed.

Topics Discussed:

What are immune checkpoint inhibitors (ICIs) and for which diseases are they used?
What are the most common side effects of ICIs to be aware of, especially cardiovascular side effects for our audience?
How do you diagnose ICI myocarditis? What are the caveats?
How do you treat ICI myocarditis? Can you resume ICI therapy once resolved?
What about other CV side effects with ICI therapy? Easy to recognize, easy to manage?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday Apr 30, 2024

How Can Genetics Help in the Management of Heart Failure?

Tuesday Apr 30, 2024

How Can Genetics Help in the Management of Heart Failure?

Guest: Naveen L. Pereira, M.D.

Hosts: Paul A. Friedman, M.D.

Cardiomyopathy is an important cause of heart failure and can be inherited or have a genetic basis. Identifying a genetic cause for cardiomyopathy not only provides a molecular diagnosis of the disease but holds significant importance in screening family members enabling early identification of disease, providing prognostic information to the patient and increasingly offers the opportunity for therapy that is genetic based. Understanding the genetics of cardiomyopathy also helps identify new pathophysiologic mechanisms of disease that may help in the development of new therapeutic targets.

Topics Discussed:

Genetic Testing as a tool to determine inherited cardiomyopathy
The yield of genetic testing for cardiomyopathy
What results can be expected after genetic testing is performed?
Can genetics provide new insight into the pathophysiology of disease, specifically cardiomyopathies?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday Apr 23, 2024

TRIO Score and Choosing Patients Most Likely to Benefit From Tricuspid Valve Intervention

Tuesday Apr 23, 2024

TRIO Score and Choosing Patients Most Likely to Benefit From Tricuspid Valve Intervention

Guest: Sorin V. Pislaru, M.D., Ph.D.

Hosts: Sharonne N. Hayes, M.D.

Tricuspid Regurgitation (TR) is an extraordinarily heterogeneous, highly prevalent valvular heart disease. Given the tremendous variability, individualizing risk in patients with TR to guide appropriate therapy will be explored. Other topics discussed will be the use of TRIO scores, GDMT as a first line in therapy, as well as when to consider surgery or percutaneous interventions.

Topics Discussed:

Is TR a relevant valvular heart disease?
Why the need for a risk score?
So what is the TRIO score
What else did you learn from the score?
The future?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday Apr 16, 2024

Deep-Learning Models for the Prognostication and Localization of Premature Ventricular Contractions Using a 12-Lead Electrocardiogram

Tuesday Apr 16, 2024

Deep-Learning Models for the Prognostication and Localization of Premature Ventricular Contractions Using a 12-Lead Electrocardiogram

Guest: Guru G. Kowlgi, M.B.B.S.

Host: Anthony H. Kashou, M.D.

In this episode, learners will understand what premature ventricular contractions are. They will learn to differentiate benign rom malignant PVCs, and understand which patients are at risk for PVC-cardiomyopathy. Furthermore, they will gain knowledge about the traditional and novel tools for risk-stratifying patients with PVCs, and how we manage these patients.

Topics Discussed

What are PVCs and what are their clinical implications?
When should we be concerned about a patient with PVCs?
What are some of the tools we have to detect and localize high risk PVCs? How does AI help in this regard?
What are the available treatment modalities for managing PVCs?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Thursday Apr 11, 2024

How to Integrate NON-Statin Therapy in Your Practice. Updates from the Latest 2022 LDL-Cholesterol Lowering Guidelines

Thursday Apr 11, 2024

How to Integrate NON-Statin Therapy in Your Practice. Updates from the Latest 2022 LDL-Cholesterol Lowering Guidelines

Guest: Regis I. Fernandes, M.D.

Hosts: Sharonne N. Hayes, M.D.

Since the last ACC/AHA cholesterol guidelines in 2018, the FDA has approved new non-statin cholesterol medications, which have increased our ability to provide a broader range of lipid-lowering drugs. In this podcast, we will discuss the new 2022 ACC expert consensus decision pathway on the role of non-statin therapies for LDL lowering in managing atherosclerotic cardiovascular disease risk. We will review these new drugs and discuss which ones to consider, when, and in what order.

Topics Discussed:

What are these new FDA-approved nonstatin drugs for lipid-lowering?
To whom and when non-statins should be considered?
Are there new LDL targets or thresholds for certain patients?
What are the new guideline recommendations for patients with statin intolerance?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday Apr 02, 2024

Lifetime Strategy in the Management of Aortic Stenosis

Tuesday Apr 02, 2024

Lifetime Strategy in the Management of Aortic Stenosis

Guest: Mackram F. Eleid, M.D. and Kevin L. Greason, M.D.

Hosts: Patricia A. Pellikka, M.D.

This topic will discuss advances in the treatment of aortic stenosis, particularly with transcatheter aortic valve replacement. Strategies to manage aortic valve disease over a patient’s lifespan will be discussed, including topics of valve in valve, choice of prosthesis type, and commissural alignment.

Topics Discussed:

How has treatment of aortic stenosis changed in the last 10 years?
What are some of the challenging decisions physicians and patients make when deciding about treatment of aortic stenosis?
Explain the concept of commisural alignment - how important is it?
What is the longevity of TAVR valves and what treatments are available if they fail?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.

Tuesday Mar 26, 2024

Reop Sternotomy - How Many is too Many?

Tuesday Mar 26, 2024

Reop Sternotomy - How Many is too Many?

Guest: Joseph A. Dearani, M.D. and Elizabeth H. Stephens, M.D., Ph.D.

Hosts: Patricia A. Pellikka, M.D.

Reoperations are inevitable for many structural heart lesions, and in some cases, it may be multiple reoperations over a lifetime. Current techniques in perioperative imaging and contemporary surgical techniques make cardiac reoperations safe in most circumstances. Lifelong surveillance with a heart team approach of both cardiology and cardiac surgery is the optimal strategy to determine the proper timing of reoperation to achieve a good outcome.

Topics Discussed:

How many reoperations can a patient have?
What are the most common reasons for the need for reoperation?
Is it true that the risk of reoperation is often the same as a first-time operation?
What matters most with patient selection for reoperation?
Can a minimally invasive approach be applied at a reoperation?
Is the length of hospital stay and postoperative recovery different with reoperation?
Do all surgeons do cardiac reoperations?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.

LinkedIn: Mayo Clinic Cardiovascular Services

No CME credit offered for this episode.

Podcast episode transcript found here.